We also evaluated the inhibitory effects of multiple inhibitors as well as alterations in PI3K/AKT and RAS/RAF/MEK/ERK downstream pathways in the EGFRwt/wt and EGFR-/- renal cancer cells. This evidence concerns the gene EGFR and renal carcinoma.